Literature DB >> 10631363

Clinical outcome and long-term survival rates after esophagectomy are not determined by age over 70 years.

J Johansson1, B Walther.   

Abstract

Esophagectomy is considered a high-risk procedure in patients aged 70 years or older. This study evaluates the impact of two age groups (younger than 70 and 70 years or older) on clinical outcome and long-term survival rates following this procedure. This prospective study included survival analysis and clinical evaluations at 3, 6, and 12 months after esophagectomy. All esophagectomy patients undergoing gastric (n = 125), jejunal (n = 10), or colonic (n = 4) reconstructions at our institution from 1984 to 1996 were included. Fifty patients were older than 70 years, 89 were younger, and 120 of these 139 patients had tumors. The overall hospital mortality rate was 1.4% (2 of 139), both in the younger age group. All leaks from anastomoses and grafts were nonfatal, and these problems occurred in seven patients in the younger age group and two in the older group. The mean preoperative weight was 70 kg, and there was a mean weight loss of 5 kg during the first three postoperative months only but none thereafter (P <0.001). This was the same for patients with benign and malignant disorders, and for those aged over or under 70 years. Between 71% and 77% of the patients experienced no dysphagia at the three evaluations during the first postoperative year. The distribution of the different grades of dysphagia was equal in the two age groups at 3-month (P = 0.339) and 12-month (P = 0.669) follow-up. The 12-year survival rate was 28% and the 5-year rate was 31%, and this was correlated to tumor stage (P = 0.002) but not to age over or under 70 years (P = 0.299). The clinical outcome was the same regardless of whether patients were over or under 70 years of age. Tumor stage but not age over 70 years was the major predictive factor for long-term survival.

Entities:  

Mesh:

Year:  2000        PMID: 10631363     DOI: 10.1016/s1091-255x(00)80033-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management.

Authors:  R T Poon; S Y Law; K M Chu; F J Branicki; J Wong
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

2.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

Review 3.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.

Authors:  K Nygaard; S Hagen; H S Hansen; R Hatlevoll; R Hultborn; A Jakobsen; M Mäntyla; H Modig; E Munck-Wikland; B Rosengren
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

Review 5.  Oesophageal squamous cell carcinoma: I. A critical review of surgery.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

Review 6.  Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.

Authors:  B A Bates; F C Detterbeck; S A Bernard; B F Qaqish; J E Tepper
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

7.  Surgery for esophageal cancer in elderly patients: the view from Nottingham.

Authors:  C Alexiou; D Beggs; F D Salama; E T Brackenbury; W E Morgan
Journal:  J Thorac Cardiovasc Surg       Date:  1998-10       Impact factor: 5.209

Review 8.  Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus: results of a study of 56 patients.

Authors:  J P Malhaire; J P Labat; P Lozac'h; H Simon; B Lucas; P Topart; A Volant
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-15       Impact factor: 7.038

9.  Multimodality therapy for adenocarcinoma of the esophagus.

Authors:  K S Naunheim; P J Petruska; T S Roy; J M Schlueter; H Kim; A E Baue
Journal:  Ann Thorac Surg       Date:  1995-05       Impact factor: 4.330

10.  Quality of life measurement in patients with oesophageal cancer.

Authors:  J M Blazeby; M H Williams; S T Brookes; D Alderson; J R Farndon
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  6 in total

1.  An investigation into the current peri-operative nutritional management of oesophageal carcinoma patients in major carcinoma centres in England.

Authors:  P M Murphy; P Modi; J Rahamim; T Wheatley; S J Lewis
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

Review 2.  Quality of complication reporting in the surgical literature.

Authors:  Robert C G Martin; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis.

Authors:  Bruno Walther; Jan Johansson; Folke Johnsson; Christer Staël Von Holstein; Thomas Zilling
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

4.  Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus.

Authors:  Masaru Morita; Akinori Egashira; Rintaro Yoshida; Keisuke Ikeda; Kippei Ohgaki; Kotaro Shibahara; Eiji Oki; Noriaki Sadanaga; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 5.  Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis.

Authors:  Styliani Mantziari; Hugo Teixeira Farinha; Vianney Bouygues; Jean-Charles Vignal; Yannick Deswysen; Nicolas Demartines; Markus Schäfer; Guillaume Piessen
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.

Authors:  Jason M Foster; Richard Sleightholm; Asish Patel; Valerie Shostrom; Bradley Hall; Beth Neilsen; David Bartlett; Lynette Smith
Journal:  JAMA Netw Open       Date:  2019-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.